Found 8 matching trials
Marizomib Central Nervous System (CNS)
PHASE2This research is being done to test whether the investigational drug marizo...
Location
Massachusetts General Hospital Cancer Center
Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma
PHASE1Multicenter, open-label study of NPI-0052 in patients with advanced solid t...
Location
Premiere Oncology of America
Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma
PHASE2Background:
Ependymomas are rare tumors that arise from the ependyma. That...
Location
National Institutes of Health Clinical Center
Phase I Study of Marizomib + Panobinostat for Children With DIPG
PHASE1This research study is evaluating the safety, tolerability and preliminary ...
Location
Boston Children's Hospital
Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer
PHASE1This study is for newly diagnosed WHO Grade IV malignant glioma patients to...
Location
University of California San Diego Medical Center
Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
PHASE2This is a Phase 2, open-label, multicenter study examining the safety, phar...
Location
Moffitt Cancer Center
Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed Glioblastoma
PHASE2Phase 2, open-label study of nab-sirolimus in patients with recurrent high ...
Location
St. Joseph Heritage Healthcare
Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab
PHASE1This is a Phase 1/2 clinical trial to evaluate a new combination of drugs, ...
Location
University of Californai, Irvine